The Neurosurgeon's Armamentarium for Gliomas: An Update on Intraoperative Technologies to Improve Extent of Resection
- PMID: 33440712
- PMCID: PMC7826675
- DOI: 10.3390/jcm10020236
The Neurosurgeon's Armamentarium for Gliomas: An Update on Intraoperative Technologies to Improve Extent of Resection
Abstract
Maximal safe resection is the standard of care in the neurosurgical treatment of high-grade gliomas. To aid surgeons in the operating room, adjuvant techniques and technologies centered around improving intraoperative visualization of tumor tissue have been developed. In this review, we will discuss the most advanced technologies, specifically fluorescence-guided surgery, intraoperative imaging, neuromonitoring modalities, and microscopic imaging techniques. The goal of these technologies is to improve detection of tumor tissue beyond what conventional microsurgery has permitted. We describe the various advances, the current state of the literature that have tested the utility of the different adjuvants in clinical practice, and future directions for improving intraoperative technologies.
Keywords: 5-ALA; extent of resection; fluorescein; fluorescence-guided surgery; glioblastoma; glioma surgery; iMRI; intraoperative imaging; neuromonitoring; ultrasound.
Conflict of interest statement
C.G.H. is a consultant for NX Development Corporation (NXDC) and Synaptive Medical. NXDC, a privately held company, markets Gleolan (5-ALA, aminolevulinic acid hydrochloride). Gleolan is an optical imaging agent approved for the visualization of malignant tissue during glioma surgery. Hadjipanayis is a consultant for NXDC and receives royalty payments for the sale of Gleolan. Hadjipanayis receives financial compensation as a consultant and lecturer for Synaptive (manufacturer of the 3D Synaptive MODUS V device). He has also received speaker fees by Carl Zeiss and Leica.
Figures




Similar articles
-
Review of Intraoperative Adjuncts for Maximal Safe Resection of Gliomas and Its Impact on Outcomes.Cancers (Basel). 2022 Nov 21;14(22):5705. doi: 10.3390/cancers14225705. Cancers (Basel). 2022. PMID: 36428797 Free PMC article. Review.
-
Novel intraoperative strategies for enhancing tumor control: Future directions.Neuro Oncol. 2022 Nov 2;24(Suppl 6):S25-S32. doi: 10.1093/neuonc/noac090. Neuro Oncol. 2022. PMID: 36322096 Free PMC article. Review.
-
Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.World Neurosurg. 2011 Jul-Aug;76(1-2):120-7. doi: 10.1016/j.wneu.2011.02.005. World Neurosurg. 2011. PMID: 21839963
-
Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.Neurosurg Focus. 2014 Feb;36(2):E3. doi: 10.3171/2013.11.FOCUS13463. Neurosurg Focus. 2014. PMID: 24484256
-
Visualization technologies for 5-ALA-based fluorescence-guided surgeries.J Neurooncol. 2019 Feb;141(3):495-505. doi: 10.1007/s11060-018-03077-9. Epub 2018 Dec 15. J Neurooncol. 2019. PMID: 30554344 Free PMC article. Review.
Cited by
-
Review of Intraoperative Adjuncts for Maximal Safe Resection of Gliomas and Its Impact on Outcomes.Cancers (Basel). 2022 Nov 21;14(22):5705. doi: 10.3390/cancers14225705. Cancers (Basel). 2022. PMID: 36428797 Free PMC article. Review.
-
Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review.J Neurooncol. 2023 Apr;162(2):267-293. doi: 10.1007/s11060-023-04274-x. Epub 2023 Mar 24. J Neurooncol. 2023. PMID: 36961622 Free PMC article.
-
Towards Optical Biopsy in Glioma Surgery.Int J Mol Sci. 2025 May 9;26(10):4554. doi: 10.3390/ijms26104554. Int J Mol Sci. 2025. PMID: 40429698 Free PMC article. Review.
-
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients.Contemp Clin Trials Commun. 2021 Aug 4;23:100830. doi: 10.1016/j.conctc.2021.100830. eCollection 2021 Sep. Contemp Clin Trials Commun. 2021. PMID: 34401600 Free PMC article.
-
Maximal Safe Resection in Glioblastoma Surgery: A Systematic Review of Advanced Intraoperative Image-Guided Techniques.Brain Sci. 2023 Jan 28;13(2):216. doi: 10.3390/brainsci13020216. Brain Sci. 2023. PMID: 36831759 Free PMC article. Review.
References
-
- Lacroix M., Abi-Said D., Fourney D.R., Gokaslan Z.L., Shi W., DeMonte F., Lang F.F., McCutcheon I.E., Hassenbusch S.J., Holland E., et al. A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J. Neurosurg. 2001;95:190–198. doi: 10.3171/jns.2001.95.2.0190. - DOI - PubMed
-
- McGirt M.J., Chaichana K.L., Gathinji M., Attenello F.J., Than K., Olivi A., Weingart J.D., Brem H., Quiñones-Hinojosa A.R. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J. Neurosurg. 2009;110:156–162. doi: 10.3171/2008.4.17536. - DOI - PubMed
-
- Hadjipanayis C.G., Stummer W. Fluorescence-Guided Neurosurgery: Neuro-Oncology and Cerebrovascular Applications. Thieme; New York, NY, USA: 2019.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources